5-Methoxy-1-[4-(trifluoromethyl)phenyl]-1-pentanone

GTC-180

Pharmaceutical Intermediates

5-Methoxy-1-[4-(trifluoromethyl)phenyl]-1-pentanone

CAS No.
61718-80-7
Catalogue ID
GTC-180

5-Methoxy-1-[4-(trifluoromethyl)phenyl]-1-pentanone, CAS 61718-80-7. Source-derived identification, physical data and applications are provided for catalogue reference; request the current specification, COA and SDS for the required grade.

Catalogue aliases / related identifiers

5-Methoxy-1-(4-(trifluoromethyl)phenyl)pentan-1-one; Fluvoxketone; 5-Methoxy-4'-(trifluoromethyl)valerophenone; Fluvoxamine Impurity D; 5-Methoxy-1-(4-trifluoromethylphenyl)pentan-1-one; 1-Pentanone, 5-methoxy-1-[4-(trifluoromethyl)phenyl]-

Supplied catalogue source: GTC-180 · Page 98

Reference data — confirm before ordering or use

The information below is a structured migration from the supplied catalogue snapshot. It is not a current product specification, COA or SDS. Confirm the actual supplier, grade, batch documents, classification, packing and destination requirements for your enquiry.

5-Methoxy-1-[4-(trifluoromethyl)phenyl]-1-pentanone is a trifluoromethyl-substituted aryl ketone with a methoxy-terminated alkyl chain. The ketone functionality allows for transformations such as oxime formation in multi-step syntheses.


Basic Information

CAS No.61718-80-7
EC No.Not available
Linear FormulaC13H15F3O2
Molecular Weight260.25
AppearanceWhite to off-white solid
Melting Point50-52 °C (lit.)
Boiling point318.7±42.0 °C (Predicted)
Density1.147±0.06 g/cm³ (Predicted)
SolubilitySoluble in chloroform, methanol; slightly soluble in water (typical reference)
Storage ConditionsSealed in dry, room temperature
Chemical StructureMolecular Structure of 5-Methoxy-1-[4-(trifluoromethyl)phenyl]-1-pentanone

Key Applications

  • Pharmaceutical intermediate: A key precursor in the synthesis of fluvoxamine, an SSRI antidepressant, via oxime intermediate formation, and an important building block within Aripiprazole and Fluvoxamine intermediates for CNS-focused API development.

  • API intermediate: Used in the production of active pharmaceutical ingredients featuring trifluoromethylated aryl ketones, making it relevant to fluorinated pharmaceutical intermediates in medicinal chemistry and process synthesis.

  • Aromatic compound synthesis: Provides a fluorinated aromatic scaffold for ketone-based transformations in organic synthesis, especially in the development of CNS drug intermediates and related fine chemicals.

  • Laboratory research: Employed in medicinal chemistry for analog development, impurity studies, and route evaluation involving fluorinated small molecules.

  • Process development: Applied in route optimization and scale-up for efficient manufacturing of fine chemical intermediates and pharmaceutical intermediates for API synthesis.


  • High batch consistency: Purity and uniformity ensured through rigorous quality controls tailored for pharmaceutical intermediate requirements.

  • Stable international supply: Dependable logistics channels supporting global export from research to production quantities.

  • Documentation provision: SDS, COA, and related certificates available to meet sourcing and compliance standards.

  • Packaging flexibility: Options including 1kg/5kg/25kg fiber drums with PE liners or customized packaging, with responsive technical support.

Before you order

Confirm the current commercial product record.

Include the required grade or purity, quantity, preferred packing, destination country/port and required document set.

  • 01Current specification
  • 02Batch or sample COA
  • 03Product- and supplier-specific SDS
  • 04Packing and shipping review
Request product review

INQUIRY

INQUIRY